What companies are RGNX's competitors?

REGENXBIO Inc. (RGNX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does RGNX compare to its peers?

The peer comparison table on this page shows REGENXBIO Inc. (RGNX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does RGNX operate in?

REGENXBIO Inc. (RGNX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

RGNX

REGENXBIO Inc.

NASDAQ·Biotechnology · Healthcare

$6.58$0.10−1.50%

After hours·$6.71+1.98%

Market cap$434.37M·Market closed·Oct 26 4:00 PM EDT

Frequently Asked Questions About RGNX

What companies are RGNX's competitors?: REGENXBIO Inc. (RGNX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does RGNX compare to its peers?: The peer comparison table on this page shows REGENXBIO Inc. (RGNX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does RGNX operate in?: REGENXBIO Inc. (RGNX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

RGNX

REGENXBIO Inc.

NASDAQ·Biotechnology · Healthcare

$6.58$0.10−1.50%

After hours·$6.71+1.98%

Market cap$434.37M·Market closed·Oct 26 4:00 PM EDT

Peers

Sort:


PGENPGENPrecigen, Inc.	Precigen, Inc.	$6.04	$2.2B
QUREQUREuniQure N.V.	uniQure N.V.	$21.65	$1.5B
MGTXMGTXMeiraGTx Holdings plc	MeiraGTx Holdings plc	$9.18	$881.7M
SLDBSLDBSolid Biosciences Inc.	Solid Biosciences Inc.	$5.81	$623.0M
FDMTFDMT4D Molecular Therapeutics, Inc.	4D Molecular Therapeutics, Inc.	$11.03	$609.3M
RCKTRCKTRocket Pharmaceuticals, Inc.	Rocket Pharmaceuticals, Inc.	$2.28	$250.3M
OCGNOCGNOcugen, Inc.	Ocugen, Inc.	$0.74	$250.0M
LXEOLXEOLexeo Therapeutics, Inc. Common Stock	Lexeo Therapeutics, Inc. Common Stock	$2.70	$221.6M
VYGRVYGRVoyager Therapeutics, Inc.	Voyager Therapeutics, Inc.	$1.75	$107.8M
GNPXGNPXGenprex, Inc.	Genprex, Inc.	$1.81	$913.9K

Frequently Asked Questions About RGNX

What companies are RGNX's competitors?: REGENXBIO Inc. (RGNX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does RGNX compare to its peers?: The peer comparison table on this page shows REGENXBIO Inc. (RGNX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does RGNX operate in?: REGENXBIO Inc. (RGNX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.